Eversept Partners, LP Argenx Se Transaction History

Eversept Partners, LP

$1.33 Billion
Q1 2024

A detailed history of Eversept Partners, LP transactions in Argenx Se stock. As of the latest transaction made, Eversept Partners, LP holds 54,518 shares of ARGX stock, worth $23.4 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

54,518

Previous 85,832 36.48%

Holding current value

$23.4 Million

Previous $32.7 Million 34.27%

% of portfolio

1.61%

Previous 3.19%

41 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $11.2 Million - $12.9 Million	-31,314 Reduced 36.48%	54,518 $21.5 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $27.5 Million - $41.1 Million	81,267 Added 1780.22%	85,832 $32.7 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $151,802 - $225,404	411 Added 9.89%	4,565 $2.24 Million
Q2 2023 Nov 08, 2023	BUY	$360.14 - $422.58 $114,524 - $134,380	318 Added 8.29%	4,154 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $114,524 - $134,380	318 Added 8.29%	4,154 $1.62 Million

Q1 2023 Nov 08, 2023	BUY	$334.23 - $403.65 $120,322 - $145,314	360 Added 10.36%	3,836 $1.43 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $120,322 - $145,314	360 Added 10.36%	3,836 $1.43 Million
Q4 2022 Nov 08, 2023	SELL	$342.17 - $402.31 $8,896 - $10,460	-26 Reduced 0.74%	3,476 $1.32 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $8,896 - $10,460	-26 Reduced 0.74%	3,476 $1.32 Million
Q3 2022 Nov 08, 2023	SELL	$343.2 - $395.75 $15.7 Million - $18.1 Million	-45,634 Reduced 92.87%	3,502 $1.24 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $15.7 Million - $18.1 Million	-45,634 Reduced 92.87%	3,502 $1.24 Million
Q2 2022 Nov 08, 2023	BUY	$269.58 - $378.88 $7.01 Million - $9.85 Million	25,994 Added 112.32%	49,136 $18.6 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $7.01 Million - $9.85 Million	25,994 Added 112.32%	49,136 $18.6 Million
Q1 2022 Nov 08, 2023	BUY	$254.45 - $351.06 $4.83 Million - $6.67 Million	18,988 Added 457.1%	23,142 $7.3 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $418,824 - $577,844	1,646 Added 7.66%	23,142 $7.3 Million
Q4 2021 Nov 08, 2023	BUY	$272.01 - $353.03 $4.28 Million - $5.56 Million	15,750 Added 274.1%	21,496 $7.53 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $4.28 Million - $5.56 Million	15,750 Added 274.1%	21,496 $7.53 Million
Q3 2021 Nov 08, 2023	SELL	$295.0 - $350.58 $8.89 Million - $10.6 Million	-30,140 Reduced 83.99%	5,746 $1.74 Million
Q3 2021 Nov 15, 2021	BUY	$295.0 - $350.58 $1.7 Million - $2.01 Million	5,746 New	5,746 $1.74 Million
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $9.23 Million - $11.5 Million	-35,886 Closed	0 $0
Q1 2021 Nov 08, 2023	BUY	$268.3 - $380.31 $8.51 Million - $12.1 Million	31,732 Added 763.89%	35,886 $9.88 Million
Q1 2021 May 13, 2021	BUY	$268.3 - $380.31 $9.63 Million - $13.6 Million	35,886 New	35,886 $9.88 Million
Q1 2020 May 13, 2020	SELL	$108.83 - $165.23 $4.05 Million - $6.15 Million	-37,204 Closed	0 $0
Q4 2019 Nov 08, 2023	BUY	$106.59 - $164.21 $127,908 - $197,052	1,200 Added 3.33%	37,204 $5.97 Million
Q4 2019 Feb 13, 2020	BUY	$106.59 - $164.21 $127,908 - $197,052	1,200 Added 3.33%	37,204 $5.97 Million
Q3 2019 Nov 08, 2023	SELL	$113.31 - $150.51 $1.39 Million - $1.85 Million	-12,260 Reduced 25.4%	36,004 $4.1 Million
Q3 2019 Nov 13, 2019	SELL	$113.31 - $150.51 $1.39 Million - $1.85 Million	-12,260 Reduced 25.4%	36,004 $4.1 Million
Q2 2019 Nov 08, 2023	BUY	$115.0 - $141.58 $1.03 Million - $1.26 Million	8,930 Added 22.7%	48,264 $6.83 Million
Q2 2019 Aug 13, 2019	BUY	$115.0 - $141.58 $1.03 Million - $1.26 Million	8,930 Added 22.7%	48,264 $6.83 Million
Q1 2019 Nov 08, 2023	BUY	$98.85 - $134.59 $109,723 - $149,394	1,110 Added 2.9%	39,334 $4.91 Million
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $109,723 - $149,394	1,110 Added 2.9%	39,334 $4.91 Million
Q4 2018 Nov 08, 2023	BUY	$63.81 - $109.82 $936,092 - $1.61 Million	14,670 Added 62.28%	38,224 $3.67 Million
Q4 2018 Feb 13, 2019	BUY	$63.81 - $109.82 $936,092 - $1.61 Million	14,670 Added 62.28%	38,224 $3.67 Million
Q3 2018 Nov 08, 2023	SELL	$75.5 - $96.63 $62,665 - $80,202	-830 Reduced 3.4%	23,554 $1.79 Million
Q3 2018 Nov 14, 2018	SELL	$75.5 - $96.63 $62,665 - $80,202	-830 Reduced 3.4%	23,554 $1.79 Million
Q2 2018 Nov 08, 2023	SELL	$74.84 - $100.16 $853,176 - $1.14 Million	-11,400 Reduced 31.86%	24,384 $2.02 Million
Q2 2018 Aug 14, 2018	SELL	$74.84 - $100.16 $853,176 - $1.14 Million	-11,400 Reduced 31.86%	24,384 $2.02 Million
Q1 2018 Nov 08, 2023	BUY	$56.95 - $85.19 $1.8 Million - $2.69 Million	31,630 Added 761.43%	35,784 $2.88 Billion
Q1 2018 May 14, 2018	BUY	$56.95 - $85.19 $462,661 - $692,083	8,124 Added 29.37%	35,784 $2.88 Million
Q4 2017 Nov 08, 2023	BUY	$22.57 - $63.56 $530,530 - $1.49 Million	23,506 Added 565.86%	27,660 $1.75 Billion
Q4 2017 Feb 12, 2018	BUY	$22.57 - $63.56 $624,286 - $1.76 Million	27,660	27,660 $1.75 Million

Others Institutions Holding ARGX

# of Institutions

356

Shares Held

31.3M

Call Options Held

212K

Put Options Held

210K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $23.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account

Eversept Partners, LP Argenx Se Transaction History